Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark
Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
BMJ Open. 2021 Oct 22;11(10):e052652. doi: 10.1136/bmjopen-2021-052652.
It is unclear whether kidney disease is a risk factor for developing dementia. We examined the association between kidney disease and risk of future dementia.
Nationwide historical registry-based cohort study in Denmark based on data from 1 January 1995 until 31 December 2016.
All patients diagnosed with kidney disease and matched general population cohort without kidney disease (matched 1:5 on age, sex and year of kidney disease diagnosis).
All-cause dementia and its subtypes: Alzheimer's disease, vascular dementia and other specified or unspecified dementia. We computed 5-year cumulative incidences (risk) and hazard ratios (HRs) for outcomes using Cox regression analyses.
The study cohort comprised 82 690 patients with kidney disease and 413 405 individuals from the general population. Five-year and ten-year mortality rates were twice as high in patients with kidney disease compared with the general population. The 5-year risk for all-cause dementia was 2.90% (95% confidence interval: 2.78% to 3.08%) in patients with kidney disease and 2.98% (2.92% to 3.04%) in the general population. Compared with the general population, the adjusted HRs for all-cause dementia in patients with kidney disease were 1.06 (1.00 to 1.12) for the 5-year follow-up and 1.08 (1.03 to 1.12) for the entire study period. Risk estimates for dementia subtypes differed substantially and were lower for Alzheimer's disease and higher for vascular dementia.
Patients diagnosed with kidney disease have a modestly increased rate of dementia, mainly driven by vascular dementia. Moreover, patients with kidney disease may be underdiagnosed with dementia due to high mortality and other comorbidities of higher priority.
目前尚不清楚肾脏疾病是否是痴呆的危险因素。本研究旨在探讨肾脏疾病与未来痴呆风险之间的关系。
这是一项在丹麦开展的全国性基于登记的历史队列研究,研究数据来源于 1995 年 1 月 1 日至 2016 年 12 月 31 日。
所有诊断为肾脏疾病的患者和未患肾脏疾病的一般人群队列(按年龄、性别和肾脏疾病诊断年份进行 1:5 匹配)。
全因痴呆及其亚型:阿尔茨海默病、血管性痴呆和其他特指或非特指痴呆。采用 Cox 回归分析计算结局的 5 年累积发生率(风险)和风险比(HR)。
研究队列包括 82690 例肾脏疾病患者和 413405 例一般人群。与一般人群相比,肾脏疾病患者的 5 年和 10 年死亡率高 1 倍。肾脏疾病患者 5 年全因痴呆的风险为 2.90%(95%置信区间:2.78%3.08%),一般人群为 2.98%(2.92%3.04%)。与一般人群相比,肾脏疾病患者的全因痴呆调整后 HR 在 5 年随访时为 1.06(1.001.12),在整个研究期间为 1.08(1.031.12)。痴呆亚型的风险估计差异较大,阿尔茨海默病的风险较低,血管性痴呆的风险较高。
诊断为肾脏疾病的患者痴呆发生率略有增加,主要与血管性痴呆有关。此外,由于较高的死亡率和其他更高优先级的合并症,肾脏疾病患者可能被漏诊为痴呆。